Calithera Biosciences Inc
Biotechnology
Healthcare
CALA
3.92 M shares
NASDAQ US
traded
06 Jan 2023
listed
yes
open
3.33
52 week high
4.88
high
3.68
52 week low
1.37
low
3.33
growth
34.07 %
previous Close
3.32
P/E ratio
-1
market cap
11.77 M
div yield
0
usd
Mar 2022
qoq
revenue
0.00 %
net incoming
-13.84 M
80.01 %
eps
-3.60 %
-1.00 %
eps surprise
2.70 %
net profit margin
-1383500000.00 %
23.07 %
operating incoming
-13.83 M
80.02 %
net change in cash
-14.87 M
40.40 %
cash on hand
44.66 M
-24.98 %
cost of revenue
0.00 %
top top